Dr. Sulaiman Al Habib Medical Services Group announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months )
| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 3,435.76 | 3,157.78 | 8.803 | 3,701.45 | -7.177 |
| Gross Profit (Loss) | 955.97 | 1,028.31 | -7.034 | 1,062.78 | -10.05 |
| Operational Profit (Loss) | 587.75 | 625.93 | -6.099 | 682.48 | -13.88 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 503.29 | 557.01 | -9.644 | 651.16 | -22.708 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 506.47 | 546.5 | -7.324 | 640.86 | -20.97 |
| All figures are in (Millions) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Total Shareholders Equity (after Deducting Minority Equity) | 7,949.69 | 7,291.14 | 9.032 |
| Profit (Loss) per Share | 1.44 | 1.59 | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Millions) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Revenues for Q1 2026 grew by 8.80% to SAR 3,435.76 million, compared to SAR 3,157.78 million in the same quarter last year, representing an increase of SAR 277.98 million. |
This growth was primarily driven by the growth in the performance of the Group’s operating segments, including the hospitals segment, the pharmacies segment, and the solutions segment, supported by higher patient volumes.
As part of its ongoing growth strategy, the Group expanded its network by adding new hospitals in key regions. Operations commenced during 2024 for Al-Fayhaa Hospital in Jeddah, Al-Sahafa Hospital in Riyadh, and the Women’s Health Hospital in Riyadh, adding a bed capacity reaching 1,200 beds during 2024. This was followed during 2025 by Al-Hamra Hospital in Riyadh, Al-Kharj Hospital, and Al-Muhammadiyah Hospital in Jeddah, adding a bed capacity reaching 800 beds.
These newly commissioned hospitals are currently in the ramp-up phase, and increasing their contribution to revenue until they reach their optimal operating levels.
Net profit for Q1 2026 decreased by (9.64%) to SAR 503.29 million, compared to SAR 557.01 million in the same quarter of the last year.
This was primarily due to the impact of fixed costs associated with the new strategic expansions on profitability margins, including higher depreciation costs and financing costs related to these expansions, which added a bed capacity reaching 2,000 beds during 2024 and 2025.
These expansions are still in the ramp-up phase, and their contribution to revenue is expected to increase gradually until these projects reach their optimal operating levels.
Additionally, the first quarter was affected by certain seasonal factors, which impacted revenue growth rates between the comparative periods.
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.